JSC
RMD icon

Jackson Square Capital’s ResMed RMD Stock Holding History

Jackson Square Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-52
Closed -$9K – 292
2020
Q3 		$9K Hold
52
– – ﹤0.01% 267
2020
Q2 		$10K Sell
52
-3
-5% -$491 0.01% 243
2020
Q1 		$8K Hold
55
– – 0.01% 236
2019
Q4 		$9K Buy
+55
New +$7.93K 0.01% 269

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jackson Square Capital's RMD Position: Q4 2020 in Review

Jackson Square Capital sold out of ResMed (RMD) in Q4 2020, closing a stake of 52 shares — an estimated $9K sold.

Jackson Square Capital first reported a position in RMD in Q4 2019 and held it in 4 quarters. The position peaked at $10K in Q2 2020. 663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

  • Jackson Square Capital reported no remaining ResMed position as of Q4 2020 after selling out during the quarter.
  • Jackson Square Capital sold 52 ResMed shares in Q4 2020, an estimated $9K.
  • Jackson Square Capital first reported a position in ResMed in Q4 2019 and held it in 4 quarters.
  • Jackson Square Capital's ResMed position peaked at $10K in Q2 2020.
  • 663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Jackson Square Capital's 13F filing for Q4 2020, filed 5 Mar 2021.